Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 197,292 | 47,010 | 32,470 | 31,990 | 131,984 |
| Marketable Securities | 315,586 | 247,380 | 247,460 | 290,308 | 163,979 |
| Receivables | 48,814 | 45,590 | 0 | 0 | 0 |
| Inventories | 20,562 | 20,950 | 0 | 0 | 0 |
| Other current assets | 0 | 11,050 | 8,380 | 17,960 | 4,290 |
| TOTAL | $593,798 | $371,980 | $288,310 | $340,258 | $300,253 |
| Non-Current Assets | |||||
| PPE Net | 55,174 | 51,390 | 10,180 | 10,313 | 9,172 |
| Other Non-Current Assets | 29,127 | 13,420 | 4,360 | 1,498 | 1,248 |
| TOTAL | $84,301 | $64,810 | $14,540 | $11,811 | $10,420 |
| Total Assets | $678,099 | $436,800 | $302,860 | $352,069 | $310,673 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,034 | 3,190 | 770 | 1,853 | 3,631 |
| Accounts payable and accrued liabilities | 11,605 | 9,480 | 3,420 | 3,303 | 2,501 |
| Accrued Expenses | 19,920 | 30,370 | 24,280 | 18,694 | 5,007 |
| Other current liabilities | N/A | 4,830 | 3,270 | 9,541 | 4,960 |
| TOTAL | $58,238 | $47,870 | $31,750 | $33,391 | $16,099 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,238 | 5,250 | 560 | 1,331 | 2,914 |
| Deferred Revenues | 4,355 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 255,769 | 86,380 | 0 | 0 | 0 |
| TOTAL | $268,737 | $91,630 | $560 | $1,331 | $2,914 |
| Total Liabilities | $326,975 | $139,510 | $32,310 | $34,722 | $19,013 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,509,653 | N/A | N/A | N/A | N/A |
| Common Shares | 189 | 40 | 30 | 30 | 29 |
| Retained earnings | -506,008 | -449,230 | -218,550 | -162,479 | -134,486 |
| Other shareholders' equity | -904 | -2,600 | -120 | 59 | -460 |
| TOTAL | $351,124 | $297,290 | $270,540 | $317,347 | $291,660 |
| Total Liabilities And Equity | $678,099 | $436,800 | $302,850 | $352,069 | $310,673 |